Visterra Adds $13M to Wrap Up Series A

Cambridge, Mass.-based Visterra has raised $13 million to complete a Series A financing round with a total of $26 million, the company said. Visterra develops medicines to prevent and treat infectious and other major diseases. The Bill & Melinda Gates Foundation and Omega Funds participated with the existing investors Polaris Venture Partners, Flagship Ventures and Lux Capital.

North AmericaUSBriefs